KEYTRUDA 25 mg/mL concentrate for solution for infusion, MDNA11
MDNA11-01
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, MDNA11 for Advanced Solid Tumors is a Phase 2 program (small_molecule) at Medicenna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Medicenna Therapeutics
- Indication
- Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active